NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.'s Avenova Brand and Business Is Fair to Shareholders

Stock Information for NovaBay Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NovaBay Pharmaceuticals Inc.

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
Niobium-Titanium Alloy Demonstrates Its Strong Market Potential in the Fabrication of Fuel Cells
NioBay Metals Receives Authorization to Drill on Zone 1 of its Foothills Property
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
Presence of High Titanium Content in the Northern Sector of the Foothills Property
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.